Dr. Michelle Weaver, MD

NPI: 1265624621
Total Payments
$953.62
2021 Payments
$16.91
Companies
17
Transactions
78
Medicare Patients
2,603
Medicare Billing
$238,085

Payment Breakdown by Category

Food & Beverage$936.11 (98.2%)
Education$17.51 (1.8%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $936.11 76 98.2%
Education $17.51 2 1.8%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $228.11 19 $0 (2018)
Novo Nordisk Inc $166.23 16 $0 (2018)
GlaxoSmithKline, LLC. $102.46 8 $0 (2018)
Purdue Pharma L.P. $74.63 5 $0 (2018)
Lilly USA, LLC $69.12 5 $0 (2018)
Allergan Inc. $61.60 5 $0 (2018)
Sunovion Pharmaceuticals Inc. $39.77 3 $0 (2017)
SANOFI-AVENTIS U.S. LLC $36.62 3 $0 (2018)
PFIZER INC. $35.35 3 $0 (2017)
Janssen Pharmaceuticals, Inc $27.72 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2021 $16.91 1 AbbVie Inc. ($16.91)
2018 $205.28 17 AstraZeneca Pharmaceuticals LP ($37.02)
2017 $731.43 60 AstraZeneca Pharmaceuticals LP ($191.09)

All Payment Transactions

78 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
11/09/2021 AbbVie Inc. QULIPTA (Drug) Food and Beverage In-kind items and services $16.91 General
Category: NEUROSCIENCE
05/22/2018 Takeda Pharmaceuticals U.S.A., Inc. Trintellix (Drug) Food and Beverage In-kind items and services $10.88 General
Category: Central Nervous System (CNS)
05/17/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $13.50 General
Category: Cardiovascular and Metabolism
05/03/2018 Merck Sharp & Dohme Corporation JANUVIA (Drug), STEGLATRO, STEGLUJAN Food and Beverage In-kind items and services $10.94 General
Category: ENDOCRINOLOGY
05/02/2018 SANOFI-AVENTIS U.S. LLC SOLIQUA (Drug) Food and Beverage In-kind items and services $13.57 General
Category: DIABETES
04/18/2018 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $12.27 General
Category: NEUROSCIENCE
04/16/2018 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $10.66 General
Category: RESPIRATORY
04/10/2018 Novo Nordisk Inc Victoza (Drug) Food and Beverage In-kind items and services $12.20 General
Category: Diabetes
03/07/2018 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $10.93 General
Category: RESPIRATORY
03/06/2018 SANOFI-AVENTIS U.S. LLC SOLIQUA (Drug) Food and Beverage In-kind items and services $11.41 General
Category: DIABETES
02/28/2018 GlaxoSmithKline, LLC. ANORO (Drug) Food and Beverage In-kind items and services $10.88 General
Category: RESPIRATORY
02/27/2018 Novo Nordisk Inc Victoza (Drug) Food and Beverage In-kind items and services $11.72 General
Category: Diabetes
02/13/2018 Lilly USA, LLC TRULICITY (Drug), BASAGLAR Food and Beverage In-kind items and services $10.60 General
Category: Diabetes
02/08/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.25 General
Category: Cardiovascular and Metabolism
02/05/2018 Daiichi Sankyo Inc. Morphabond ER (Drug) Food and Beverage In-kind items and services $12.50 General
Category: Pain Management
01/23/2018 Purdue Pharma L.P. SYMPROIC (Drug), HYSINGLA ER Food and Beverage Cash or cash equivalent $14.92 General
Category: CONSTIPATION
01/09/2018 Purdue Pharma L.P. OXYCONTIN (Drug), SYMPROIC, HYSINGLA ER Food and Beverage Cash or cash equivalent $14.78 General
Category: PAIN MANAGEMENT
01/04/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $12.27 General
Category: Cardiovascular and Metabolism
12/14/2017 Novo Nordisk Inc Victoza (Drug), Tresiba Food and Beverage In-kind items and services $13.35 General
Category: Diabetes
11/30/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.25 General
Category: Cardiovascular and Metabolism
11/29/2017 Lilly USA, LLC TRULICITY (Drug), BASAGLAR Food and Beverage In-kind items and services $11.25 General
Category: Diabetes
11/22/2017 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Education In-kind items and services $5.00 General
Category: Cardiovascular and Metabolism
11/15/2017 Purdue Pharma L.P. OXYCONTIN (Drug), SYMPROIC, HYSINGLA ER Food and Beverage Cash or cash equivalent $15.95 General
Category: PAIN MANAGEMENT
11/14/2017 Novo Nordisk Inc Victoza (Drug), Xultophy 100/3.6, Tresiba Food and Beverage In-kind items and services $9.08 General
Category: Diabetes
11/09/2017 Novo Nordisk Inc Victoza (Drug), Tresiba Food and Beverage In-kind items and services $11.44 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 798 1,041 $788,303 $74,180
2022 13 1,037 1,376 $946,250 $96,005
2021 13 768 962 $557,098 $67,900
Total Patients
2,603
Total Services
3,379
Medicare Billing
$238,085
Procedure Codes
37

All Medicare Procedures & Services

37 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 155 170 $280,990 $19,961 7.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 144 172 $128,140 $14,061 11.0%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 121 265 $104,145 $13,920 13.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 103 116 $67,164 $8,711 13.0%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 101 103 $109,453 $7,907 7.2%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 67 101 $21,614 $3,289 15.2%
99291 Critical care, first 30-74 minutes Facility 2023 20 20 $39,365 $2,974 7.6%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 31 33 $18,282 $1,719 9.4%
99292 Critical care, each additional 30 minutes Facility 2023 11 11 $12,034 $815.65 6.8%
99283 Emergency department visit with low level of medical decision making Facility 2023 12 12 $4,794 $613.41 12.8%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 33 38 $2,322 $209.21 9.0%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 191 232 $384,944 $30,382 7.9%
99219 Initial hospital observation care per day, typically 50 minutes Facility 2022 131 151 $105,269 $13,108 12.5%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 107 246 $91,931 $12,587 13.7%
99284 Emergency department visit for problem of high severity Facility 2022 91 102 $117,183 $9,255 7.9%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 77 89 $49,131 $6,864 14.0%
99217 Hospital observation care on day of discharge Facility 2022 117 135 $51,271 $6,565 12.8%
99225 Follow-up observation care per day, typically 25 minutes Facility 2022 82 97 $36,163 $4,654 12.9%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 60 136 $28,656 $3,750 13.1%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 33 36 $26,624 $3,558 13.4%
99283 Emergency department visit for problem of moderate severity Facility 2022 52 53 $32,654 $2,654 8.1%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 30 31 $16,880 $2,190 13.0%
71045 X-ray of chest, 1 view Facility 2022 32 34 $2,824 $228.10 8.1%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 34 34 $2,720 $210.06 7.7%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 85 90 $154,020 $12,332 8.0%

About Dr. Michelle Weaver, MD

Dr. Michelle Weaver, MD is a Emergency Medicine healthcare provider based in Warren, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1265624621.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Weaver, MD has received a total of $953.62 in payments from pharmaceutical and medical device companies, with $16.91 received in 2021. These payments were reported across 78 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($936.11).

As a Medicare-enrolled provider, Weaver has provided services to 2,603 Medicare beneficiaries, totaling 3,379 services with total Medicare billing of $238,085. Data is available for 3 years (2021–2023), covering 37 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Other Specialties Family Medicine
  • Location Warren, AR
  • Active Since 08/09/2007
  • Last Updated 06/12/2024
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1265624621

Products in Payments

  • FARXIGA (Drug) $212.20
  • Victoza (Drug) $133.98
  • TRULICITY (Drug) $69.12
  • BREO (Drug) $58.70
  • OXYCONTIN (Drug) $43.76
  • SOLIQUA (Drug) $36.62
  • ANORO (Drug) $32.83
  • XARELTO (Drug) $27.72
  • VRAYLAR (Drug) $26.30
  • Myrbetriq (Drug) $24.38
  • VIAGRA (Drug) $24.37
  • QULIPTA (Drug) $16.91
  • HYSINGLA ER (Drug) $15.95
  • UTIBRON (Drug) $15.68
  • SYMPROIC (Drug) $14.92
  • STIOLTO (Drug) $13.41
  • SEEBRI (Drug) $12.70
  • Trulance (Drug) $12.51
  • Morphabond ER (Drug) $12.50
  • BYSTOLIC (Drug) $12.27

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Warren